SCHEMBL7136146

SCHEMBL7136146

CC[C@@H]([C]=O)NC(=O)[C@@H](NC)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7610492 0.79 ALDH1A1 (0.34) —
SCHEMBL18048549 0.76 MMP2 (0.37) —
SCHEMBL7139196 0.76 DPP4 (0.47) —
SCHEMBL18048550 0.76 MMP2 (0.37) —
SCHEMBL8217798 0.73 CTSD (0.31) —
SCHEMBL10296077 0.72 TSHR (0.36) —
SCHEMBL13050548 0.72 TSHR (0.36) —
SCHEMBL12733457 0.72 TSHR (0.36) —
SCHEMBL17305534 0.71 ALDH1A1 (0.56) —
SCHEMBL19750966 0.71 ALDH1A1 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6632795-B1 Treatment of cancer BASF AKTIENGESELLSCHAFT (DE) 2003-10-14 — — US claimed
EP-0981358-B1 DOLASTATIN-15 DERIVATIVES IN COMBINATION WITH TAXANES BASF AG (DE) 2003-05-28 — — EP claimed
US-6103698-A USEFUL IN TREATING CANCER IN A MAMMAL; IN COMBINATION WITH PACLITAXEL AND TAXOTERE BASF AKTIENGESELLSCHAFT (DE) 2000-08-15 — — US claimed
US-6015790-A Methods and compositions for treating rheumatoid arthritis BASF AKTIENGESELLSCHAFT (DE) 2000-01-18 — — US claimed
Send feedback